T2 Biosystems recently announced a new CEO, John McDonough – previously President of Cytyc Development – to replace venture investor and Founding CEO Douglas Levinson of Flagship Ventures. In addition...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)